OSTEONIC Past Earnings Performance
Past criteria checks 2/6
OSTEONIC has been growing earnings at an average annual rate of 98.2%, while the Medical Equipment industry saw earnings growing at 17.7% annually. Revenues have been growing at an average rate of 28.3% per year. OSTEONIC's return on equity is 10.9%, and it has net margins of 19%.
Key information
98.2%
Earnings growth rate
93.2%
EPS growth rate
| Medical Equipment Industry Growth | 22.7% |
| Revenue growth rate | 28.3% |
| Return on equity | 10.9% |
| Net Margin | 19.0% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
There May Be Underlying Issues With The Quality Of OSTEONIC's (KOSDAQ:226400) Earnings
Nov 19
There May Be Underlying Issues With The Quality Of OSTEONIC's (KOSDAQ:226400) Earnings
Mar 31Recent updates
There May Be Underlying Issues With The Quality Of OSTEONIC's (KOSDAQ:226400) Earnings
Nov 19Does OSTEONIC (KOSDAQ:226400) Have A Healthy Balance Sheet?
Nov 15OSTEONIC (KOSDAQ:226400) Is Experiencing Growth In Returns On Capital
Aug 09There May Be Underlying Issues With The Quality Of OSTEONIC's (KOSDAQ:226400) Earnings
Mar 31OSTEONIC (KOSDAQ:226400) Seems To Use Debt Rather Sparingly
Feb 27Is Osteonic (KOSDAQ:226400) A Risky Investment?
Mar 25Revenue & Expenses Breakdown
How OSTEONIC makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 32,543 | 6,181 | 6,261 | 1,915 |
| 30 Jun 24 | 31,125 | 5,882 | 6,226 | 1,769 |
| 31 Mar 24 | 29,247 | 4,445 | 5,968 | 1,537 |
| 31 Dec 23 | 27,799 | 3,658 | 6,262 | 1,254 |
| 30 Sep 23 | 25,973 | 470 | 5,766 | 586 |
| 30 Jun 23 | 24,342 | -452 | 5,740 | 458 |
| 31 Mar 23 | 22,131 | -171 | 5,455 | 484 |
| 31 Dec 22 | 19,839 | 836 | 4,926 | 454 |
| 30 Sep 22 | 18,116 | 2,345 | 5,760 | 297 |
| 30 Jun 22 | 17,269 | 2,264 | 5,492 | 302 |
| 31 Mar 22 | 16,338 | -70 | 5,629 | 267 |
| 31 Dec 21 | 15,598 | -2,852 | 5,062 | 256 |
Quality Earnings: A226400 has a high level of non-cash earnings.
Growing Profit Margin: A226400's current net profit margins (19%) are higher than last year (1.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if A226400's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare A226400's past year earnings growth to its 5-year average.
Earnings vs Industry: A226400 earnings growth over the past year (1214.4%) exceeded the Medical Equipment industry 7.6%.
Return on Equity
High ROE: A226400's Return on Equity (10.9%) is considered low.